Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/SCPHARMACEUTICALS INC/ EFFECT

SEC Filing · EFFECT

SCPHARMACEUTICALS INC

SEC Filing

Filed Nov 19, 2025Accepted Nov 19, 2025, 7:15 PM ESTCIK 1604950Accession 9999999995-25-003314
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
SCPHOTC · EQUITY · Historical · closed Oct 6, 2025

Recent company filings

  1. SCHEDULE 13G/A - filed by Weiss Asset Management LP regarding scPharmaceuticals Inc.Feb 11, 2026
  2. EFFECT filingNov 19, 2025
  3. EFFECT filingNov 19, 2025
  4. SCHEDULE 13G - filed by Weiss Asset Management LP regarding scPharmaceuticals Inc.Nov 12, 2025
  5. 15-12G filingOct 17, 2025

As-filed source

Primary evidence
As filedOpen full document ↗